Study of Dexycu in Treating Intraocular Inflammation
Clinical trial NCT06429306 · COMPLETED
Trial details
- NCT number
- NCT06429306
- Sponsor
- Ocumension Therapeutics (Shanghai) Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-22
- Primary completion
- 2023-11-24
- Enrollment
- 285
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.